{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "07",
                "@timestamp": "2023-08-07T23:43:31.000031-04:00",
                "@year": "2023",
                "@month": "08"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2023",
                "@month": "06"
            }
        },
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Germany",
                            "@afid": "60103459",
                            "@country": "deu",
                            "city": "Munich",
                            "organization": [
                                {"$": "Department of Urology"},
                                {"$": "Rechts der Isar Medical Center"},
                                {"$": "Technical University of Munich"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60103459",
                                    "@dptid": "120275127"
                                },
                                {"@afid": "60019722"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-949724837-d5f03155ec859a455b0e4b12b73c84c2-1",
                            "ce:source-text": "Department of Urology, Rechts der Isar Medical Center, Technical University of Munich, Munich, Germany",
                            "@dptid": "120275127"
                        },
                        "author": [
                            {
                                "ce:given-name": "Lukas",
                                "preferred-name": {
                                    "ce:given-name": "Lukas",
                                    "ce:initials": "L.",
                                    "ce:surname": "Lunger",
                                    "ce:indexed-name": "Lunger L."
                                },
                                "@author-instance-id": "OB2BibRecID-949724837-05d38964f2ec209582619c97fe2e40af-1",
                                "@seq": "1",
                                "ce:initials": "L.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Lunger",
                                "@auid": "57192208572",
                                "ce:indexed-name": "Lunger L."
                            },
                            {
                                "ce:given-name": "Robert",
                                "preferred-name": {
                                    "ce:given-name": "Robert",
                                    "ce:initials": "R.",
                                    "ce:surname": "Tauber",
                                    "ce:indexed-name": "Tauber R."
                                },
                                "@author-instance-id": "OB2BibRecID-949724837-8c02a8abb4405d3266bb6c780deb89c7-1",
                                "@seq": "8",
                                "ce:initials": "R.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Tauber",
                                "@auid": "16048592600",
                                "ce:indexed-name": "Tauber R."
                            },
                            {
                                "ce:given-name": "Stefan",
                                "preferred-name": {
                                    "ce:given-name": "Stefan",
                                    "ce:initials": "S.",
                                    "ce:surname": "Schiele",
                                    "ce:indexed-name": "Schiele S."
                                },
                                "@author-instance-id": "OB2BibRecID-949724837-3a97c7875a9b89c3bd54604f8dc05882-1",
                                "@seq": "9",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Schiele",
                                "@auid": "57209242549",
                                "ce:indexed-name": "Schiele S."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Germany",
                            "@afid": "60103459",
                            "@country": "deu",
                            "city": "Munich",
                            "organization": [
                                {"$": "Department of Nuclear Medicine"},
                                {"$": "Rechts der Isar Medical Center"},
                                {"$": "Technical University of Munich"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60103459",
                                    "@dptid": "120275128"
                                },
                                {"@afid": "60019722"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-949724837-7cec034e036213f1ade2e7683f893872-1",
                            "ce:source-text": "Department of Nuclear Medicine, Rechts der Isar Medical Center, Technical University of Munich, Munich, Germany; and",
                            "@dptid": "120275128"
                        },
                        "author": [
                            {
                                "ce:given-name": "Maythinee",
                                "preferred-name": {
                                    "ce:given-name": "Maythinee",
                                    "ce:initials": "M.",
                                    "ce:surname": "Chantadisai",
                                    "ce:indexed-name": "Chantadisai M."
                                },
                                "@author-instance-id": "OB2BibRecID-949724837-a84061829ef2d3fb35768275d4861dd9-1",
                                "@seq": "2",
                                "ce:initials": "M.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Chantadisai",
                                "@auid": "56183484200",
                                "ce:indexed-name": "Chantadisai M."
                            },
                            {
                                "ce:given-name": "Amir",
                                "preferred-name": {
                                    "ce:given-name": "Amir",
                                    "ce:initials": "A.",
                                    "ce:surname": "Karimzadeh",
                                    "ce:indexed-name": "Karimzadeh A."
                                },
                                "@author-instance-id": "OB2BibRecID-949724837-b27b7c573523be93f9bc42844cc9ddab-1",
                                "@seq": "3",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Karimzadeh",
                                "@auid": "57926489600",
                                "ce:indexed-name": "Karimzadeh A."
                            },
                            {
                                "ce:given-name": "Isabel",
                                "preferred-name": {
                                    "ce:given-name": "Isabel",
                                    "ce:initials": "I.",
                                    "ce:surname": "Rauscher",
                                    "ce:indexed-name": "Rauscher I."
                                },
                                "@author-instance-id": "OB2BibRecID-949724837-de2f0436d7056af87139cef6b464555b-1",
                                "@seq": "4",
                                "ce:initials": "I.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Rauscher",
                                "@auid": "25646320300",
                                "ce:indexed-name": "Rauscher I."
                            },
                            {
                                "ce:given-name": "Calogero",
                                "preferred-name": {
                                    "ce:given-name": "Calogero",
                                    "ce:initials": "C.",
                                    "ce:surname": "D\u2019Alessandria",
                                    "ce:indexed-name": "D\u2019Alessandria C."
                                },
                                "@author-instance-id": "OB2BibRecID-949724837-e64bae20a754cec391887d3215c611d3-1",
                                "@seq": "5",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "D\u2019Alessandria",
                                "@auid": "8510830000",
                                "ce:indexed-name": "D'Alessandria C."
                            },
                            {
                                "ce:given-name": "Benedikt",
                                "preferred-name": {
                                    "ce:given-name": "Benedikt",
                                    "ce:initials": "B.",
                                    "ce:surname": "Feuerecker",
                                    "ce:indexed-name": "Feuerecker B."
                                },
                                "@author-instance-id": "OB2BibRecID-949724837-01f3ca7a30b6a1a3767da2880ea770b6-1",
                                "@seq": "6",
                                "ce:initials": "B.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Feuerecker",
                                "@auid": "55644376000",
                                "ce:indexed-name": "Feuerecker B."
                            },
                            {
                                "ce:given-name": "Thomas",
                                "preferred-name": {
                                    "ce:given-name": "Thomas",
                                    "ce:initials": "T.",
                                    "ce:surname": "Langbein",
                                    "ce:indexed-name": "Langbein T."
                                },
                                "@author-instance-id": "OB2BibRecID-949724837-b6d859b5e24729b0de171c8fd47cd271-1",
                                "@seq": "7",
                                "ce:initials": "T.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Langbein",
                                "@auid": "57200324173",
                                "ce:indexed-name": "Langbein T."
                            },
                            {
                                "ce:given-name": "Wolfgang",
                                "preferred-name": {
                                    "ce:given-name": "Wolfgang",
                                    "ce:initials": "W.",
                                    "ce:surname": "Weber",
                                    "ce:indexed-name": "Weber W."
                                },
                                "@author-instance-id": "OB2BibRecID-949724837-69fc9ea5ccccc4cfecc260a0134e1e37-1",
                                "@seq": "10",
                                "ce:initials": "W.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Weber",
                                "@auid": "7402748205",
                                "ce:indexed-name": "Weber W."
                            },
                            {
                                "ce:given-name": "Matthias",
                                "preferred-name": {
                                    "ce:given-name": "Matthias",
                                    "ce:initials": "M.",
                                    "ce:surname": "Eiber",
                                    "ce:indexed-name": "Eiber M."
                                },
                                "@author-instance-id": "OB2BibRecID-949724837-a01f27ba5cf82af7f0c08bfa68bffc67-1",
                                "@seq": "11",
                                "ce:initials": "M.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Eiber",
                                "@auid": "16835828400",
                                "ce:indexed-name": "Eiber M."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Nuclear Medicine"},
                                {"$": "Department of Radiology"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"},
                                {"$": "King Chulalongkorn Memorial Hospital"},
                                {"$": "Thai Red Cross Society"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002620",
                                    "@dptid": "103183428"
                                },
                                {"@afid": "60031780"},
                                {"@afid": "60022183"},
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-949724837-2033579de9ee1b8699157b881810cf02-1",
                            "ce:source-text": "Division of Nuclear Medicine, Department of Radiology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand",
                            "@dptid": "103183428"
                        },
                        "author": [{
                            "ce:given-name": "Maythinee",
                            "preferred-name": {
                                "ce:given-name": "Maythinee",
                                "ce:initials": "M.",
                                "ce:surname": "Chantadisai",
                                "ce:indexed-name": "Chantadisai M."
                            },
                            "@author-instance-id": "OB2BibRecID-949724837-a84061829ef2d3fb35768275d4861dd9-1",
                            "@seq": "2",
                            "ce:initials": "M.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Chantadisai",
                            "@auid": "56183484200",
                            "ce:indexed-name": "Chantadisai M."
                        }]
                    }
                ],
                "citation-title": "Prognostic Role of 68Ga-PSMA11 PET\u2013Based Response in Patients with Prostate Cancer Undergoing Taxane-Based Chemotherapy",
                "abstracts": "Â© 2023 by the Society of Nuclear Medicine and Molecular Imaging.This study was performed to assess the prognostic utility of conventional biochemical and imaging response criteria and 68Ga-PSMA11 PET\u2013adapted or \u2013specific systems regarding overall survival (OS) in men with metastatic hormone-sensitive and castration-resistant prostate cancer (PC) treated with taxane-based chemotherapy. Methods: A total of 103 patients (metastatic hormone-sensitive PC, n = 57; castration-resistant PC, n = 46) underwent taxane-based chemotherapy. All patients had a minimum of 2 prostate-specific membrane antigen (PSMA) PET scans (at baseline and up to 3 mo after treatment). PSMA PET response was assessed by RECIST 1.1, adapted Prostate Cancer Working Group Criteria 3 (using PSMA PET instead of bone scan), aPERCIST, and PSMA PET progression (PPP) criteria. Response by each criterion was stratified by either progressive disease (PD) or non-PD. For aPERCIST, stratification by PD, stable disease (SD), and partial/complete remission (PR/CR) was performed. Biochemical response was determined by a prostate-specific antigen decrease of at least 50%. Subgroup analyses were performed by castration status. Univariable Cox proportional hazards regression analyses including Harrell\u2019s concordance indices were calculated to investigate the association of PD by response criteria and OS. Kaplan\u2013Meier tests including log-rank statistics were calculated for survival analyses. Results: Twenty-six (25%) patients had unmeasurable disease by RECIST 1.1. PD by any response criterion was associated with an at least 2.5-fold increased risk of death and was highest for PD versus CR/PR by aPERCIST (hazard ratio, 11.4) on univariable regression. Stratified by castration status, a similar pattern was observed. PD by any criterion as associated with significantly shortened OS across overall and subgroup analyses. PR/CR by aPERCIST identified patients with lower risk of death and longer OS compared with patients with PD or SD. Conclusion: PSMA PET\u2013based response criteria (PPP, aPERCIST, adapted Prostate Cancer Working Group Criteria 3) have high prognostic utility in men with metastatic PC undergoing taxane-based chemotherapy. PPP is simple to use, identified most patients with PD, and showed best prognostic utility regarding OS. PR/CR by aPERCIST identifies a subgroup of responders (PR/CR) showing better outcomes than patients with PD or SD. Future studies are warranted to amend the current paradigm relying on mere differentiation of PD versus non-PD in metastatic PC and to identify true treatment responders by imaging criteria.",
                "correspondence": {
                    "affiliation": {
                        "country": "Germany",
                        "@country": "deu",
                        "city": "Munich",
                        "organization": [
                            {"$": "Department of Urology"},
                            {"$": "Rechts der Isar Medical Center"},
                            {"$": "Technical University of Munich"}
                        ],
                        "@affiliation-instance-id": "OB2BibRecID-949724837-d5f03155ec859a455b0e4b12b73c84c2-1",
                        "ce:source-text": "Department of Urology, Rechts der Isar Medical Center, Technical University of Munich, Munich, Germany"
                    },
                    "person": {
                        "ce:given-name": "Lukas",
                        "@author-instance-id": "OB2BibRecID-949724837-655c3c02c21d6d06e11d71ab8a4f693f-1",
                        "ce:initials": "L.",
                        "ce:surname": "Lunger",
                        "ce:indexed-name": "Lunger L."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "68Ga-PSMA11 PET/CT",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "metastatic prostate cancer",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "survival",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "taxane-based chemotherapy",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "treatment monitoring",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "https://jnm.snmjournals.org/content/64/6/896",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Journal of Nuclear Medicine",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "64",
                            "@issue": "6"
                        },
                        "pagerange": {
                            "@first": "896",
                            "@last": "901"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Journal of Nuclear Medicine",
                    "publicationdate": {
                        "month": "06",
                        "year": "2023",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "1 June 2023"
                        },
                        "day": "01"
                    },
                    "codencode": "JNMEA",
                    "sourcetitle-abbrev": "J. Nucl. Med.",
                    "@country": "usa",
                    "issn": [
                        {
                            "$": "2159662X",
                            "@type": "electronic"
                        },
                        {
                            "$": "01615505",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2023"},
                    "publisher": {"publishername": "Society of Nuclear Medicine Inc."},
                    "@srcid": "17230"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "16",
                                    "classification-description": "Cancer"
                                },
                                {
                                    "classification-code": "23",
                                    "classification-description": "Nuclear Medicine"
                                },
                                {
                                    "classification-code": "28",
                                    "classification-description": "Urology and Nephrology"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": "2741"
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MEDI"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": "1906894-20-9",
                                    "chemical-name": "gallium gozetotide ga 68"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "7440-55-3"},
                                        {"$": "14391-02-7"}
                                    ],
                                    "chemical-name": "gallium"
                                },
                                {
                                    "cas-registry-number": "7439-94-3",
                                    "chemical-name": "lutetium"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Gallium Radioisotopes"},
                                {"chemical-name": "Heterocyclic Compounds, 1-Ring"},
                                {"chemical-name": "Hormones"},
                                {"chemical-name": "Lutetium"},
                                {"chemical-name": "Prostate-Specific Antigen"},
                                {"chemical-name": "taxane"},
                                {"chemical-name": "Taxoids"}
                            ]
                        }
                    ]}
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2023 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "MEDLINE",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "03",
                    "@timestamp": "BST 09:45:54",
                    "@year": "2023",
                    "@month": "08"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2025781018",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "639913136",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "949724837",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20230708187",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "36581373",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20232142602",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20232808799",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "2023902137519X",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85160970129",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85160970129",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "639913136",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "76462999",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.2967/jnumed.122.264962"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "21",
                "reference": [
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A. recent global patterns in prostate cancer incidence and mortality rates. Eur Urol. 2020;77:38\u201352.",
                        "@reference-instance-id": "OB2BibRecID-949724837-5bec00b97a75a1ae63cdb67e9caf91a5-1",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "recent global patterns in prostate cancer incidence and mortality rates"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85071656769",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "77"},
                                "pagerange": {
                                    "@first": "38",
                                    "@last": "52"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "MB",
                                    "@_fa": "true",
                                    "ce:surname": "Culp",
                                    "ce:indexed-name": "Culp MB"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "I",
                                    "@_fa": "true",
                                    "ce:surname": "Soerjomataram",
                                    "ce:indexed-name": "Soerjomataram I"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "JA",
                                    "@_fa": "true",
                                    "ce:surname": "Efstathiou",
                                    "ce:indexed-name": "Efstathiou JA"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "F",
                                    "@_fa": "true",
                                    "ce:surname": "Bray",
                                    "ce:indexed-name": "Bray F"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Jemal",
                                    "ce:indexed-name": "Jemal A."
                                }
                            ]},
                            "ref-sourcetitle": "Eur Urol"
                        },
                        "ce:source-text": "Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A. recent global patterns in prostate cancer incidence and mortality rates. Eur Urol. 2020;77:38\u201352."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Francini E, Gray KP, Shaw GK, et al. Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry. Prostate Cancer Prostatic Dis. 2019;22:420\u2013427.",
                        "@reference-instance-id": "OB2BibRecID-949724837-40523cedcd3db4a022171e842e0cca2a-2",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85060103137",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "22"},
                                "pagerange": {
                                    "@first": "420",
                                    "@last": "427"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Francini",
                                        "ce:indexed-name": "Francini E"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "KP",
                                        "@_fa": "true",
                                        "ce:surname": "Gray",
                                        "ce:indexed-name": "Gray KP"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "GK",
                                        "@_fa": "true",
                                        "ce:surname": "Shaw",
                                        "ce:indexed-name": "Shaw GK"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Prostate Cancer Prostatic Dis"
                        },
                        "ce:source-text": "Francini E, Gray KP, Shaw GK, et al. Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry. Prostate Cancer Prostatic Dis. 2019;22:420\u2013427."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Marques RB, Dits NF, Erkens-Schulze S, van Weerden WM, Jenster G. Bypass mechanisms of the androgen receptor pathway in therapy-resistant prostate cancer cell models. PLoS One. 2010;5:e13500.",
                        "@reference-instance-id": "OB2BibRecID-949724837-d2813605ce0e03f893bc2bc28e54b5e9-3",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Bypass mechanisms of the androgen receptor pathway in therapy-resistant prostate cancer cell models"},
                            "refd-itemidlist": {"itemid": {
                                "$": "78149435915",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "5"},
                                "pagerange": {"@first": "e13500"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "RB",
                                    "@_fa": "true",
                                    "ce:surname": "Marques",
                                    "ce:indexed-name": "Marques RB"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "NF",
                                    "@_fa": "true",
                                    "ce:surname": "Dits",
                                    "ce:indexed-name": "Dits NF"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Erkens-Schulze",
                                    "ce:indexed-name": "Erkens-Schulze S"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "WM",
                                    "@_fa": "true",
                                    "ce:surname": "van Weerden",
                                    "ce:indexed-name": "van Weerden WM"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Jenster",
                                    "ce:indexed-name": "Jenster G."
                                }
                            ]},
                            "ref-sourcetitle": "PLoS One"
                        },
                        "ce:source-text": "Marques RB, Dits NF, Erkens-Schulze S, van Weerden WM, Jenster G. Bypass mechanisms of the androgen receptor pathway in therapy-resistant prostate cancer cell models. PLoS One. 2010;5:e13500."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Scher HI, Morris MJ, Stadler WM, et al. Trial design and objectives for castration-resistant prostate cancer: updated recommendations from the Prostate Cancer Clinical Trials Working Group 3. J Clin Oncol. 2016;34:1402\u20131418.",
                        "@reference-instance-id": "OB2BibRecID-949724837-75ac2e9e857077aa6eddcffb1e45afd2-4",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Trial design and objectives for castration-resistant prostate cancer: updated recommendations from the Prostate Cancer Clinical Trials Working Group 3"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84966339540",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "34"},
                                "pagerange": {
                                    "@first": "1402",
                                    "@last": "1418"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "HI",
                                        "@_fa": "true",
                                        "ce:surname": "Scher",
                                        "ce:indexed-name": "Scher HI"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MJ",
                                        "@_fa": "true",
                                        "ce:surname": "Morris",
                                        "ce:indexed-name": "Morris MJ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "WM",
                                        "@_fa": "true",
                                        "ce:surname": "Stadler",
                                        "ce:indexed-name": "Stadler WM"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Scher HI, Morris MJ, Stadler WM, et al. Trial design and objectives for castration-resistant prostate cancer: updated recommendations from the Prostate Cancer Clinical Trials Working Group 3. J Clin Oncol. 2016;34:1402\u20131418."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Hofman MS, Lawrentschuk N, Francis RJ, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 2020;395:1208\u20131216.",
                        "@reference-instance-id": "OB2BibRecID-949724837-d47273dda7d6fbcfe63f399fb73bb673-5",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85082773271",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "395"},
                                "pagerange": {
                                    "@first": "1208",
                                    "@last": "1216"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MS",
                                        "@_fa": "true",
                                        "ce:surname": "Hofman",
                                        "ce:indexed-name": "Hofman MS"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Lawrentschuk",
                                        "ce:indexed-name": "Lawrentschuk N"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "RJ",
                                        "@_fa": "true",
                                        "ce:surname": "Francis",
                                        "ce:indexed-name": "Francis RJ"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Hofman MS, Lawrentschuk N, Francis RJ, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 2020;395:1208\u20131216."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Mottet N, van den Bergh RCN, Briers E, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Accessed July 27, 2022. https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-EANM-ESTRO-ESUR-ISUP_SIOG-Guidelines-onProstate-Cancer-2022_2022-04-25-063938_yfos.pdf",
                        "@reference-instance-id": "OB2BibRecID-949724837-91e5189b2f61fffc0e8c5b428f087c25-6",
                        "@id": "6",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-EANM-ESTRO-ESUR-ISUP_SIOG-Guidelines-onProstate-Cancer-2022_2022-04-25-063938_yfos.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85014846613",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed July 27, 2022",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Mottet",
                                        "ce:indexed-name": "Mottet N"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "RCN",
                                        "@_fa": "true",
                                        "ce:surname": "van den Bergh",
                                        "ce:indexed-name": "van den Bergh RCN"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Briers",
                                        "ce:indexed-name": "Briers E"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "EAU-ESTRO-SIOG guidelines on prostate cancer"
                        },
                        "ce:source-text": "Mottet N, van den Bergh RCN, Briers E, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Accessed July 27, 2022. https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-EANM-ESTRO-ESUR-ISUP_SIOG-Guidelines-onProstate-Cancer-2022_2022-04-25-063938_yfos.pdf"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Oncology Program Guidelines (German Cancer Society, German Cancer Aid, AWMF): S3 guideline prostate cancer, long version 6.2, 2021, AWMF register number: 043/022OL. Accessed July 27, 2022. http://www.leitlinienprogrammonkologie.de/leitlinien/prostatakarzinom/",
                        "@reference-instance-id": "OB2BibRecID-949724837-23de8a8f722465bd4d80660fcbeb0c5d-7",
                        "@id": "7",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.leitlinienprogrammonkologie.de/leitlinien/prostatakarzinom/",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85165935211",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed July 27, 2022",
                            "ref-sourcetitle": "Oncology Program Guidelines (German Cancer Society, German Cancer Aid, AWMF): S3 guideline prostate cancer, long version 6.2, 2021, AWMF register number: 043/022OL"
                        },
                        "ce:source-text": "Oncology Program Guidelines (German Cancer Society, German Cancer Aid, AWMF): S3 guideline prostate cancer, long version 6.2, 2021, AWMF register number: 043/022OL. Accessed July 27, 2022. http://www.leitlinienprogrammonkologie.de/leitlinien/prostatakarzinom/"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Weber WA, Wieder H. Monitoring chemotherapy and radiotherapy of solid tumors. Eur J Nucl Med Mol Imaging. 2006;33(suppl 1):27\u201337.",
                        "@reference-instance-id": "OB2BibRecID-949724837-b8909dbd928b233633aeb1676670e5c2-8",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Monitoring chemotherapy and radiotherapy of solid tumors"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33746539507",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "33"},
                                "pagerange": {
                                    "@first": "27",
                                    "@last": "37"
                                }
                            },
                            "ref-text": "(suppl 1)",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "WA",
                                    "@_fa": "true",
                                    "ce:surname": "Weber",
                                    "ce:indexed-name": "Weber WA"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Wieder",
                                    "ce:indexed-name": "Wieder H."
                                }
                            ]},
                            "ref-sourcetitle": "Eur J Nucl Med Mol Imaging"
                        },
                        "ce:source-text": "Weber WA, Wieder H. Monitoring chemotherapy and radiotherapy of solid tumors. Eur J Nucl Med Mol Imaging. 2006;33(suppl 1):27\u201337."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Juweid ME, Cheson BD. Positron-emission tomography and assessment of cancer therapy. N Engl J Med. 2006;354:496\u2013507.",
                        "@reference-instance-id": "OB2BibRecID-949724837-189c50b2e75d3eb43013358b1d47a621-9",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Positron-emission tomography and assessment of cancer therapy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "32044438650",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "354"},
                                "pagerange": {
                                    "@first": "496",
                                    "@last": "507"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "ME",
                                    "@_fa": "true",
                                    "ce:surname": "Juweid",
                                    "ce:indexed-name": "Juweid ME"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "BD.",
                                    "@_fa": "true",
                                    "ce:surname": "Cheson",
                                    "ce:indexed-name": "Cheson BD."
                                }
                            ]},
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Juweid ME, Cheson BD. Positron-emission tomography and assessment of cancer therapy. N Engl J Med. 2006;354:496\u2013507."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Fanti S, Hadaschik B, Herrmann K. Proposal for systemic-therapy response-assessment criteria at the time of PSMA PET/CT imaging: the PSMA PET progression criteria. J Nucl Med. 2020;61:678\u2013682.",
                        "@reference-instance-id": "OB2BibRecID-949724837-74152d1a815daabf816aa2783b3abbea-10",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Proposal for systemic-therapy response-assessment criteria at the time of PSMA PET/CT imaging: the PSMA PET progression criteria"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85084961224",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "61"},
                                "pagerange": {
                                    "@first": "678",
                                    "@last": "682"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Fanti",
                                    "ce:indexed-name": "Fanti S"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "B",
                                    "@_fa": "true",
                                    "ce:surname": "Hadaschik",
                                    "ce:indexed-name": "Hadaschik B"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Herrmann",
                                    "ce:indexed-name": "Herrmann K."
                                }
                            ]},
                            "ref-sourcetitle": "J Nucl Med"
                        },
                        "ce:source-text": "Fanti S, Hadaschik B, Herrmann K. Proposal for systemic-therapy response-assessment criteria at the time of PSMA PET/CT imaging: the PSMA PET progression criteria. J Nucl Med. 2020;61:678\u2013682."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Seitz AK, Rauscher I, Haller B, et al. Preliminary results on response assessment using (68)Ga-HBED-CC-PSMA PET/CT in patients with metastatic prostate cancer undergoing docetaxel chemotherapy. Eur J Nucl Med Mol Imaging. 2018;45: 602\u2013612.",
                        "@reference-instance-id": "OB2BibRecID-949724837-4d08b0c2b2b244da1b6c23d1bd5616b8-11",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Preliminary results on response assessment using (68)Ga-HBED-CC-PSMA PET/CT in patients with metastatic prostate cancer undergoing docetaxel chemotherapy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85035085566",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "45"},
                                "pagerange": {
                                    "@first": "602",
                                    "@last": "612"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "AK",
                                        "@_fa": "true",
                                        "ce:surname": "Seitz",
                                        "ce:indexed-name": "Seitz AK"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I",
                                        "@_fa": "true",
                                        "ce:surname": "Rauscher",
                                        "ce:indexed-name": "Rauscher I"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Haller",
                                        "ce:indexed-name": "Haller B"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur J Nucl Med Mol Imaging"
                        },
                        "ce:source-text": "Seitz AK, Rauscher I, Haller B, et al. Preliminary results on response assessment using (68)Ga-HBED-CC-PSMA PET/CT in patients with metastatic prostate cancer undergoing docetaxel chemotherapy. Eur J Nucl Med Mol Imaging. 2018;45: 602\u2013612."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Has Simsek D, Kuyumcu S, Karadogan S, et al. Can PSMA-based tumor burden predict response to docetaxel treatment in metastatic castration-resistant prostate cancer? Ann Nucl Med. 2021;35:680\u2013690.",
                        "@reference-instance-id": "OB2BibRecID-949724837-c11b4ea3160c4f7ee4a3561327e1088c-12",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Can PSMA-based tumor burden predict response to docetaxel treatment in metastatic castration-resistant prostate cancer?"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85103923796",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "35"},
                                "pagerange": {
                                    "@first": "680",
                                    "@last": "690"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Has Simsek",
                                        "ce:indexed-name": "Has Simsek D"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Kuyumcu",
                                        "ce:indexed-name": "Kuyumcu S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Karadogan",
                                        "ce:indexed-name": "Karadogan S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Nucl Med"
                        },
                        "ce:source-text": "Has Simsek D, Kuyumcu S, Karadogan S, et al. Can PSMA-based tumor burden predict response to docetaxel treatment in metastatic castration-resistant prostate cancer? Ann Nucl Med. 2021;35:680\u2013690."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Shagera QA, Artigas C, Karfis I, et al. (68)Ga-PSMA PET/CT for response assessment and outcome prediction in metastatic prostate cancer patients treated with taxane-based chemotherapy. J Nucl Med. 2022;63:1191\u20131198.",
                        "@reference-instance-id": "OB2BibRecID-949724837-92917f58c101ef25a593a68e4daff7e3-13",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "(68)Ga-PSMA PET/CT for response assessment and outcome prediction in metastatic prostate cancer patients treated with taxane-based chemotherapy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85129941696",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "63"},
                                "pagerange": {
                                    "@first": "1191",
                                    "@last": "1198"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "QA",
                                        "@_fa": "true",
                                        "ce:surname": "Shagera",
                                        "ce:indexed-name": "Shagera QA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Artigas",
                                        "ce:indexed-name": "Artigas C"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "I",
                                        "@_fa": "true",
                                        "ce:surname": "Karfis",
                                        "ce:indexed-name": "Karfis I"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Nucl Med"
                        },
                        "ce:source-text": "Shagera QA, Artigas C, Karfis I, et al. (68)Ga-PSMA PET/CT for response assessment and outcome prediction in metastatic prostate cancer patients treated with taxane-based chemotherapy. J Nucl Med. 2022;63:1191\u20131198."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Alongi P, Laudicella R, Lanzafame H, et al. PSMA and choline PET for the assessment of response to therapy and survival outcomes in prostate cancer patients: a systematic review from the literature. Cancers (Basel). 2022;14:1770.",
                        "@reference-instance-id": "OB2BibRecID-949724837-1e43f078de71545f00a96c09b5881f02-14",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "PSMA and choline PET for the assessment of response to therapy and survival outcomes in prostate cancer patients: a systematic review from the literature"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85127379333",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {"@first": "1770"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Alongi",
                                        "ce:indexed-name": "Alongi P"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Laudicella",
                                        "ce:indexed-name": "Laudicella R"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Lanzafame",
                                        "ce:indexed-name": "Lanzafame H"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancers (Basel)"
                        },
                        "ce:source-text": "Alongi P, Laudicella R, Lanzafame H, et al. PSMA and choline PET for the assessment of response to therapy and survival outcomes in prostate cancer patients: a systematic review from the literature. Cancers (Basel). 2022;14:1770."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Schwartz LH, Litiere S, de Vries E, et al. RECIST 1.1: update and clarification\u2014from the RECIST committee. Eur J Cancer. 2016;62:132\u2013137.",
                        "@reference-instance-id": "OB2BibRecID-949724837-48f1388b696a3c32bdd5bbe147497b42-15",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "RECIST 1.1: update and clarification\u2014from the RECIST committee"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84967007007",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "62"},
                                "pagerange": {
                                    "@first": "132",
                                    "@last": "137"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "LH",
                                        "@_fa": "true",
                                        "ce:surname": "Schwartz",
                                        "ce:indexed-name": "Schwartz LH"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Litiere",
                                        "ce:indexed-name": "Litiere S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "de Vries",
                                        "ce:indexed-name": "de Vries E"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur J Cancer"
                        },
                        "ce:source-text": "Schwartz LH, Litiere S, de Vries E, et al. RECIST 1.1: update and clarification\u2014from the RECIST committee. Eur J Cancer. 2016;62:132\u2013137."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50(suppl 1): 122s\u2013150s.",
                        "@reference-instance-id": "OB2BibRecID-949724837-1ce8b800db06b098a71570f0bccd8337-16",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors"},
                            "refd-itemidlist": {"itemid": {
                                "$": "66149139452",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "50"},
                                "pagerange": {
                                    "@first": "122s",
                                    "@last": "150s"
                                }
                            },
                            "ref-text": "(suppl 1)",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "RL",
                                    "@_fa": "true",
                                    "ce:surname": "Wahl",
                                    "ce:indexed-name": "Wahl RL"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H",
                                    "@_fa": "true",
                                    "ce:surname": "Jacene",
                                    "ce:indexed-name": "Jacene H"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "Y",
                                    "@_fa": "true",
                                    "ce:surname": "Kasamon",
                                    "ce:indexed-name": "Kasamon Y"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "MA.",
                                    "@_fa": "true",
                                    "ce:surname": "Lodge",
                                    "ce:indexed-name": "Lodge MA."
                                }
                            ]},
                            "ref-sourcetitle": "J Nucl Med"
                        },
                        "ce:source-text": "Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50(suppl 1): 122s\u2013150s."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "World Medical Association. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ. 2001;79:373\u2013374.",
                        "@reference-instance-id": "OB2BibRecID-949724837-c47c1a6c4e7fb386237bc73ff31517e8-17",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2001"},
                            "ref-title": {"ref-titletext": "World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0035049888",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "79"},
                                "pagerange": {
                                    "@first": "373",
                                    "@last": "374"
                                }
                            },
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "World Medical Association",
                                "ce:indexed-name": "World Medical Association"
                            }},
                            "ref-sourcetitle": "Bull World Health Organ"
                        },
                        "ce:source-text": "World Medical Association. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ. 2001;79:373\u2013374."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Eiber M, Herrmann K, Calais J, et al. Prostate cancer molecular imaging standardized evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-ligand PET/CT. J Nucl Med. 2018;59:469\u2013478.",
                        "@reference-instance-id": "OB2BibRecID-949724837-1808a13925d184ffa28ca8fc182fb58b-18",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Prostate cancer molecular imaging standardized evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-ligand PET/CT"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85044237349",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "59"},
                                "pagerange": {
                                    "@first": "469",
                                    "@last": "478"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Eiber",
                                        "ce:indexed-name": "Eiber M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Herrmann",
                                        "ce:indexed-name": "Herrmann K"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Calais",
                                        "ce:indexed-name": "Calais J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Nucl Med"
                        },
                        "ce:source-text": "Eiber M, Herrmann K, Calais J, et al. Prostate cancer molecular imaging standardized evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-ligand PET/CT. J Nucl Med. 2018;59:469\u2013478."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u2013247.",
                        "@reference-instance-id": "OB2BibRecID-949724837-18e00012d6c092ffec0ddb096c6cd7c5-19",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)"},
                            "refd-itemidlist": {"itemid": {
                                "$": "57849117384",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "45"},
                                "pagerange": {
                                    "@first": "228",
                                    "@last": "247"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "EA",
                                        "@_fa": "true",
                                        "ce:surname": "Eisenhauer",
                                        "ce:indexed-name": "Eisenhauer EA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Therasse",
                                        "ce:indexed-name": "Therasse P"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Bogaerts",
                                        "ce:indexed-name": "Bogaerts J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur J Cancer"
                        },
                        "ce:source-text": "Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u2013247."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Gafita A, Rauscher I, Fendler WP, et al. Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria. Eur J Nucl Med Mol Imaging. 2022;49:4271\u20134281.",
                        "@reference-instance-id": "OB2BibRecID-949724837-7520a10299655be2194e9df11faa9187-20",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85133292146",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "49"},
                                "pagerange": {
                                    "@first": "4271",
                                    "@last": "4281"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Gafita",
                                        "ce:indexed-name": "Gafita A"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I",
                                        "@_fa": "true",
                                        "ce:surname": "Rauscher",
                                        "ce:indexed-name": "Rauscher I"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "WP",
                                        "@_fa": "true",
                                        "ce:surname": "Fendler",
                                        "ce:indexed-name": "Fendler WP"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur J Nucl Med Mol Imaging"
                        },
                        "ce:source-text": "Gafita A, Rauscher I, Fendler WP, et al. Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria. Eur J Nucl Med Mol Imaging. 2022;49:4271\u20134281."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Shah RB, Mehra R, Chinnaiyan AM, et al. Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program. Cancer Res. 2004;64:9209\u20139216.",
                        "@reference-instance-id": "OB2BibRecID-949724837-154886c0639ecac291148ecdc1c87815-21",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program"},
                            "refd-itemidlist": {"itemid": {
                                "$": "10844235652",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "64"},
                                "pagerange": {
                                    "@first": "9209",
                                    "@last": "9216"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "RB",
                                        "@_fa": "true",
                                        "ce:surname": "Shah",
                                        "ce:indexed-name": "Shah RB"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Mehra",
                                        "ce:indexed-name": "Mehra R"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "AM",
                                        "@_fa": "true",
                                        "ce:surname": "Chinnaiyan",
                                        "ce:indexed-name": "Chinnaiyan AM"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Res"
                        },
                        "ce:source-text": "Shah RB, Mehra R, Chinnaiyan AM, et al. Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program. Cancer Res. 2004;64:9209\u20139216."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Munich",
            "@id": "60103459",
            "affilname": "Klinikum Rechts der Isar",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60103459",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85160970129",
        "dc:description": "This study was performed to assess the prognostic utility of conventional biochemical and imaging response criteria and 68Ga-PSMA11 PET\u2013adapted or \u2013specific systems regarding overall survival (OS) in men with metastatic hormone-sensitive and castration-resistant prostate cancer (PC) treated with taxane-based chemotherapy. Methods: A total of 103 patients (metastatic hormone-sensitive PC, n = 57; castration-resistant PC, n = 46) underwent taxane-based chemotherapy. All patients had a minimum of 2 prostate-specific membrane antigen (PSMA) PET scans (at baseline and up to 3 mo after treatment). PSMA PET response was assessed by RECIST 1.1, adapted Prostate Cancer Working Group Criteria 3 (using PSMA PET instead of bone scan), aPERCIST, and PSMA PET progression (PPP) criteria. Response by each criterion was stratified by either progressive disease (PD) or non-PD. For aPERCIST, stratification by PD, stable disease (SD), and partial/complete remission (PR/CR) was performed. Biochemical response was determined by a prostate-specific antigen decrease of at least 50%. Subgroup analyses were performed by castration status. Univariable Cox proportional hazards regression analyses including Harrell\u2019s concordance indices were calculated to investigate the association of PD by response criteria and OS. Kaplan\u2013Meier tests including log-rank statistics were calculated for survival analyses. Results: Twenty-six (25%) patients had unmeasurable disease by RECIST 1.1. PD by any response criterion was associated with an at least 2.5-fold increased risk of death and was highest for PD versus CR/PR by aPERCIST (hazard ratio, 11.4) on univariable regression. Stratified by castration status, a similar pattern was observed. PD by any criterion as associated with significantly shortened OS across overall and subgroup analyses. PR/CR by aPERCIST identified patients with lower risk of death and longer OS compared with patients with PD or SD. Conclusion: PSMA PET\u2013based response criteria (PPP, aPERCIST, adapted Prostate Cancer Working Group Criteria 3) have high prognostic utility in men with metastatic PC undergoing taxane-based chemotherapy. PPP is simple to use, identified most patients with PD, and showed best prognostic utility regarding OS. PR/CR by aPERCIST identifies a subgroup of responders (PR/CR) showing better outcomes than patients with PD or SD. Future studies are warranted to amend the current paradigm relying on mere differentiation of PD versus non-PD in metastatic PC and to identify true treatment responders by imaging criteria.",
        "pubmed-id": "36581373",
        "prism:coverDate": "2023-06-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85160970129",
        "dc:creator": {"author": [{
            "ce:given-name": "Lukas",
            "preferred-name": {
                "ce:given-name": "Lukas",
                "ce:initials": "L.",
                "ce:surname": "Lunger",
                "ce:indexed-name": "Lunger L."
            },
            "@seq": "1",
            "ce:initials": "L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60103459",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60103459"
            },
            "ce:surname": "Lunger",
            "@auid": "57192208572",
            "author-url": "https://api.elsevier.com/content/author/author_id/57192208572",
            "ce:indexed-name": "Lunger L."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85160970129"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85160970129&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85160970129&origin=inward"
            }
        ],
        "source-id": "17230",
        "citedby-count": "1",
        "prism:volume": "64",
        "subtype": "ar",
        "dc:title": "Prognostic Role of 68Ga-PSMA11 PET\u2013Based Response in Patients with Prostate Cancer Undergoing Taxane-Based Chemotherapy",
        "openaccess": "0",
        "prism:issn": "2159662X 01615505",
        "publishercopyright": "Â© 2023 by the Society of Nuclear Medicine and Molecular Imaging.",
        "prism:issueIdentifier": "6",
        "subtypeDescription": "Article",
        "prism:publicationName": "Journal of Nuclear Medicine",
        "prism:pageRange": "896-901",
        "prism:endingPage": "901",
        "openaccessFlag": "false",
        "prism:doi": "10.2967/jnumed.122.264962",
        "prism:startingPage": "896",
        "dc:identifier": "SCOPUS_ID:85160970129",
        "dc:publisher": "Society of Nuclear Medicine Inc."
    },
    "idxterms": {"mainterm": [
        {
            "$": "Gallium Radioisotopes",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Heterocyclic Compounds, 1-Ring",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Hormones",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Lutetium",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Male",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Positron Emission Tomography Computed Tomography",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Prognosis",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Prostate-Specific Antigen",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Prostatic Neoplasms, Castration-Resistant",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Retrospective Studies",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Taxoids",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Treatment Outcome",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "68Ga-PSMA11 PET/CT"
        },
        {
            "@_fa": "true",
            "$": "metastatic prostate cancer"
        },
        {
            "@_fa": "true",
            "$": "survival"
        },
        {
            "@_fa": "true",
            "$": "taxane-based chemotherapy"
        },
        {
            "@_fa": "true",
            "$": "treatment monitoring"
        }
    ]},
    "subject-areas": {"subject-area": [{
        "@_fa": "true",
        "$": "Radiology, Nuclear Medicine and Imaging",
        "@code": "2741",
        "@abbrev": "MEDI"
    }]},
    "authors": {"author": [
        {
            "ce:given-name": "Lukas",
            "preferred-name": {
                "ce:given-name": "Lukas",
                "ce:initials": "L.",
                "ce:surname": "Lunger",
                "ce:indexed-name": "Lunger L."
            },
            "@seq": "1",
            "ce:initials": "L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60103459",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60103459"
            },
            "ce:surname": "Lunger",
            "@auid": "57192208572",
            "author-url": "https://api.elsevier.com/content/author/author_id/57192208572",
            "ce:indexed-name": "Lunger L."
        },
        {
            "ce:given-name": "Maythinee",
            "preferred-name": {
                "ce:given-name": "Maythinee",
                "ce:initials": "M.",
                "ce:surname": "Chantadisai",
                "ce:indexed-name": "Chantadisai M."
            },
            "@seq": "2",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60103459",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60103459"
                },
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                }
            ],
            "ce:surname": "Chantadisai",
            "@auid": "56183484200",
            "author-url": "https://api.elsevier.com/content/author/author_id/56183484200",
            "ce:indexed-name": "Chantadisai M."
        },
        {
            "ce:given-name": "Amir",
            "preferred-name": {
                "ce:given-name": "Amir",
                "ce:initials": "A.",
                "ce:surname": "Karimzadeh",
                "ce:indexed-name": "Karimzadeh A."
            },
            "@seq": "3",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60103459",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60103459"
            },
            "ce:surname": "Karimzadeh",
            "@auid": "57926489600",
            "author-url": "https://api.elsevier.com/content/author/author_id/57926489600",
            "ce:indexed-name": "Karimzadeh A."
        },
        {
            "ce:given-name": "Isabel",
            "preferred-name": {
                "ce:given-name": "Isabel",
                "ce:initials": "I.",
                "ce:surname": "Rauscher",
                "ce:indexed-name": "Rauscher I."
            },
            "@seq": "4",
            "ce:initials": "I.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60103459",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60103459"
            },
            "ce:surname": "Rauscher",
            "@auid": "25646320300",
            "author-url": "https://api.elsevier.com/content/author/author_id/25646320300",
            "ce:indexed-name": "Rauscher I."
        },
        {
            "ce:given-name": "Calogero",
            "preferred-name": {
                "ce:given-name": "Calogero",
                "ce:initials": "C.",
                "ce:surname": "D\u2019Alessandria",
                "ce:indexed-name": "D\u2019Alessandria C."
            },
            "@seq": "5",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60103459",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60103459"
            },
            "ce:surname": "D\u2019Alessandria",
            "@auid": "8510830000",
            "author-url": "https://api.elsevier.com/content/author/author_id/8510830000",
            "ce:indexed-name": "D'Alessandria C."
        },
        {
            "ce:given-name": "Benedikt",
            "preferred-name": {
                "ce:given-name": "Benedikt",
                "ce:initials": "B.",
                "ce:surname": "Feuerecker",
                "ce:indexed-name": "Feuerecker B."
            },
            "@seq": "6",
            "ce:initials": "B.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60103459",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60103459"
            },
            "ce:surname": "Feuerecker",
            "@auid": "55644376000",
            "author-url": "https://api.elsevier.com/content/author/author_id/55644376000",
            "ce:indexed-name": "Feuerecker B."
        },
        {
            "ce:given-name": "Thomas",
            "preferred-name": {
                "ce:given-name": "Thomas",
                "ce:initials": "T.",
                "ce:surname": "Langbein",
                "ce:indexed-name": "Langbein T."
            },
            "@seq": "7",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60103459",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60103459"
            },
            "ce:surname": "Langbein",
            "@auid": "57200324173",
            "author-url": "https://api.elsevier.com/content/author/author_id/57200324173",
            "ce:indexed-name": "Langbein T."
        },
        {
            "ce:given-name": "Robert",
            "preferred-name": {
                "ce:given-name": "Robert",
                "ce:initials": "R.",
                "ce:surname": "Tauber",
                "ce:indexed-name": "Tauber R."
            },
            "@seq": "8",
            "ce:initials": "R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60103459",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60103459"
            },
            "ce:surname": "Tauber",
            "@auid": "16048592600",
            "author-url": "https://api.elsevier.com/content/author/author_id/16048592600",
            "ce:indexed-name": "Tauber R."
        },
        {
            "ce:given-name": "Stefan",
            "preferred-name": {
                "ce:given-name": "Stefan",
                "ce:initials": "S.",
                "ce:surname": "Schiele",
                "ce:indexed-name": "Schiele S."
            },
            "@seq": "9",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60103459",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60103459"
            },
            "ce:surname": "Schiele",
            "@auid": "57209242549",
            "author-url": "https://api.elsevier.com/content/author/author_id/57209242549",
            "ce:indexed-name": "Schiele S."
        },
        {
            "ce:given-name": "Wolfgang",
            "preferred-name": {
                "ce:given-name": "Wolfgang",
                "ce:initials": "W.",
                "ce:surname": "Weber",
                "ce:indexed-name": "Weber W."
            },
            "@seq": "10",
            "ce:initials": "W.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60103459",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60103459"
            },
            "ce:surname": "Weber",
            "@auid": "7402748205",
            "author-url": "https://api.elsevier.com/content/author/author_id/7402748205",
            "ce:indexed-name": "Weber W."
        },
        {
            "ce:given-name": "Matthias",
            "preferred-name": {
                "ce:given-name": "Matthias",
                "ce:initials": "M.",
                "ce:surname": "Eiber",
                "ce:indexed-name": "Eiber M."
            },
            "@seq": "11",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60103459",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60103459"
            },
            "ce:surname": "Eiber",
            "@auid": "16835828400",
            "author-url": "https://api.elsevier.com/content/author/author_id/16835828400",
            "ce:indexed-name": "Eiber M."
        }
    ]}
}}